CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement
- 4 Open-market sale Director sold 8,886 shares at $9.70 ($86,159)
- 4 Open-market sale Director sold 37,046 shares at an average $10.54 ($390,647)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes Director gave up 30,296 shares (to pay taxes)
- 4 Returned to the company Chief Commercial Officer returned 1,125 shares (to the company)
- 4 Returned to the company Chief R&D Officer returned 657 shares (to the company)
- 4 Returned to the company VP Peripheral Nerve Science returned 405 shares (to the company)
- 4 Returned to the company Chief Strategy and BD Officer returned 751 shares (to the company)
- 4 Returned to the company VP Operations returned 657 shares (to the company)
- 4 Returned to the company CEO returned 9,081 shares (to the company)
- 4 Returned to the company EVP & Chief Financial Officer returned 947 shares (to the company)
- 4 Returned to the company Chief Human Resources Officer returned 657 shares (to the company)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations · Executive or director change
- 8-K Event Executive or director change · Regulation FD disclosure
Page 18 of 69 · 1,369 filings